NASDAQ: ACHLAchilles Therapeutics PLC Stock Ownership - Who owns Achilles Therapeutics?
Insider buying vs selling
Have Achilles Therapeutics PLC insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when ACHL insiders and whales buy or sell their stock.
ACHL Shareholders
What type of owners hold Achilles Therapeutics PLC stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Syncona Portfolio Ltd | 26.99% | 11,086,909 | $8.89M | Institution |
| Fcpm Iii Services Bv | 5.82% | 2,390,050 | $1.92M | Institution |
| Artal Group Sa | 5.49% | 2,255,375 | $1.81M | Institution |
| Baker Bros Advisors LP | 5.12% | 2,102,792 | $1.69M | Institution |
| Redmile Group LLC | 3.91% | 1,608,089 | $1.29M | Institution |
| Point72 Asset Management LP | 3.44% | 1,413,809 | $1.13M | Institution |
| Renaissance Technologies LLC | 1.21% | 498,995 | $400.19k | Institution |
| Citadel Advisors LLC | 0.26% | 108,454 | $86.98k | Institution |
| Vestal Point Capital LP | 0.26% | 108,083 | $86.68k | Institution |
| Forefront Analytics LLC | 0.19% | 76,269 | $61.17k | Institution |
ACHL vs Biotech Stocks
Achilles Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.